This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

ACL's play for pathology company Healius faces pushback from Australian regulator

( July 19, 2023, 23:45 GMT | Official Statement) -- MLex Summary: Australian Clinical Labs’ bid to acquire human-pathology peer Healius is facing regulatory headwinds, with the country’s competition regulator saying that the deal raises “significant preliminary competition concerns.” In a statement of issues published today, the Australian Competition & Consumer Commission said it was concerned that the proposed deal “would be likely to substantially lessen competition in Australian pathology services markets.” “The proposed acquisition would combine two of the top three providers of pathology services in Australia, significantly increasing concentration in already concentrated markets,” ACCC Commissioner Stephen Ridgeway said. The full statement from the ACCC follows. The statement of issues is attached. ...

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login

Documents

Related Sections